openPR Logo
Press release

Smoking Cessation Products Market Estimated to Grow at a CAGR of 10.8% during Forecast Period 2019-2028 || Key Players - Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer Inc., Perrigo Company plc, Cipla Ltd., ITC Limited

06-07-2019 03:06 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

/ PR Agency: Fact.MR
Smoking Cessation Products Market Estimated to Grow at a CAGR of 10.8% during Forecast Period 2019-2028 || Key Players - Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer Inc., Perrigo Company plc, Cipla Ltd., ITC Limited

The Fact.MR has recently updated its massive report catalogue by adding a fresh study titled “Smoking Cessation Products Market Estimated to Grow at a CAGR of 10.8% during Forecast Period 2019-2028”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2028. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with a growth of manufacturers in the global market for Smoking Cessation Products. Along with these insights, the report provides the readers with crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.

A prevalence of around 251 million patients with COPD was report across the globe in 2016 by a WHO report, and it will become the third leading cause of death by 2030. As smoking tobacco is the primary cause of COPD, manufacturers in the smoking cessation products market are promoting the use of various types of smoking cessation products to prevent it.

Additionally, consumers are becoming aware that there is no cure for the life-threatening disease, thereby, the growing needs for preventing COPD is boosting adoption of smoking cessation products. Offering personalized smoking cessation products to facilitate COPD management for patients can help smoking cessation products market players to improve sales and gain an edge in the smoking cessation products market in coming years.

To Get Sample Copy of Report, Click here @ www.factmr.com/connectus/sample?flag=S&rep_id=2372

Governmental organizations across the world have introduced laws and regulations on marketing and distribution of smoking cessation products to address the public health concerns associated with tobacco use and use of smoking cessation products such as electronic cigarettes.

The U.S. Food and Drug Administration (FDA) has amended the Family Smoking Prevention and Tobacco Control Act and declared that vaping products and smoking cessation products, such as e-cigarettes, are subject to the Federal Food, Drug, and Cosmetic Act. The Government of Canada also enacted the Tobacco and Vaping Products Act (TVPA), which regulated manufacturing and sales of various smoking cessation products, including e-cigarettes, in Canada. Also, the UK Government introduced new rules under the Tobacco Products Directive 2014/14/EU (TPD) to regulate smoking cessation products, such as nicotine-containing electronic cigarettes and refill containers.

Leading countries enacting regulations on manufacturing, marketing, and distribution of e-cigarettes and other types of smoking cessation products is likely to create barriers for players in the smoking cessation products market. Smoke-free air laws imposed by various national and international governmental organizations across various countries hold a major share in the growth of the smoking cessation products market. Smoke-free laws mainly aim at protecting consumers from secondhand smoking and restrict minors’ exposure to tobacco-smoking products. The New Zealand government has developed ‘Smoke-free Environments Regulations 2007’, which imposed labeling requirements on all tobacco products to discourage smoking. Washington, DC, the U.S. capital, has imposed ‘The Department of Health Functions Clarification Amendment Act of 2006’ that bans smoking in most public places.

Growth prospects of the smoking cessation products market are moderately attributed to smoke-free air laws, as these laws limit promotion and advertising of tobacco products and indirectly encourage consumers to quit smoking. Stringent regulations and laws that discourage smoking may exhort the smoker population to turn to smoking cessation products, which may complement growth of the smoking cessation products market in the upcoming years.

Browse Complete Report with TOC @ www.factmr.com/report/2372/smoking-cessation-products-market

The Fact.MR report on smoking cessation products market enlists leading stakeholders in the market to provide insightful information about recent developments in the winning strategies of leading competitors in the smoking cessation products market. This chapter features comprehensive information, including intensity mapping, key financials, market share analysis, key developments, SWOT analysis, SIC, NACE, & NIACS codes, and global manufacturing facilities, about the each smoking cessation products market player mentioned above. The report provides detailed information about the leading market players including Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer, Inc, Perrigo Company plc, Cipla Ltd., ITC Limited, Reynolds American Inc., Imperial tobacco ltd., Fertin Pharma, and Alkalon A/S.

Johnson & Johnson Development Corp., a frontrunner in the smoking cessation products market, recently joined Carrot Inc., a digital health company New York Life Ventures and to raise over US$ 25 million to commercialize Pivot™ – smoking cessation program. The company is contributing to the project with its technological expertise in the medical device and pharmaceutical sector to establish stronger position in the smoking cessation products market.

Another frontrunner in the smoking cessation products market, GlaxoSmithKline plc. announced, in collaboration with an American pharmaceutical company –   Innoviva, Inc., that the European Commission has authorized expansion of its single inhaler triple therapy – once-daily Trelegy Ellipta. The company is aiming to adopt innovative strategies to offer an inhaler therapy for COPD patients and strengthen its foothold in the smoking cessation products market.

Imperial Brands PLC, a British player in smoking cessation products market, has adopted strategies to focus on its blu e-cigarette brand by investing over GBP100 million for further expanding its e-cigarette product portfolio in the coming year. Via its subsidiary Fontem Ventures, the company launched its new e-smoking cessation product– myblu™ in the U.S. in February 2018, and later in three further markets – France, Russia, and Germany. With launch of the new e-smoking cessation product, Imperial Brands is aiming to set a benchmark in the e-vaporing category of products in the smoking cessation market.

Other players in the smoking cessation products market, including Cipla Ltd., are adopting innovative marketing strategies, such as promotions of social media and unique commercials to spread awareness about tobacco hazards, to boost sales of their smoking cessation products.

Enquire about this Report @ www.factmr.com/connectus/sample?flag=AE&rep_id=2372

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Smoking Cessation Products Market Estimated to Grow at a CAGR of 10.8% during Forecast Period 2019-2028 || Key Players - Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer Inc., Perrigo Company plc, Cipla Ltd., ITC Limited here

News-ID: 1768356 • Views: 315

More Releases from Fact.MR

Belt Loaders Market Projections Deliver Positive Revenue Growth during 2018-2028 …
The purpose of this comprehensive forecast report presented by FactMR is to elaborate the various market projections impacting the global belt loaders market trends during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are expected to reshape
06-20-2019 | Sports
Fact.MR
Bicycle Parking Racks Market Outlook and Growth Stance Forecasted Through 2028 | …
Fact.MR published an exclusive forecast report for the bicycle parking rack market between 2018 and 2026. The foremost objective of this report on bicycle parking rack market is pitch spearhead insights on market scenario, demand generators, and technological advancements in bicycle parking rack market. Also, the study on bicycle parking rack market addresses key dynamics, which are expected to diversify the sales and future prominence of bicycle parking rack market. The
Global Basalt Fibers Market to Surpass a Notable CAGR At 8.5% through 2028, Find …
The purpose of this comprehensive forecast report presented by FactMR is to elaborate the various market projections impacting the global basalt fibers market size during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are expected to reshape
06-20-2019 | Sports
Fact.MR
Motocross Gears Market Assessment Covering Growth Factors and Upcoming Trends (2 …
In a recent Fact.MR study, motocross gears market has been evaluated at US$ 1320 Mn in 2017 as per the latest market trends and the encouraging nature of motocross gears market. International Motorcycling Federation (FIM), which conducts all the motorcycle races, has launched many championships and races that play a vital role in the growth of motocross gears market. The study predicts the motocross gear market to achieve 4.9% CAGR through 2028. The demand

All 26796 Releases


More Releases for Johnson

Catheters Market - Evolution Landscape 2025 | Medtronics, Inc., Johnson & Johnso …
Global Catheters Market: Snapshot Catheters are medical tubes that are inserted in the body cavities, vessels, or ducts to remove fluids, perform a surgery, or treat diseases. Whereas, catheters are mostly used for removing fluids by inserting in body cavities, particularly the bladder. These flexible tubes play a very significant role for aged people and patients with medical conditions that impairs the ability to urinate. Connected to the drainage bags, these
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Global Steroid-Corticosteroids Market 2018 - GlaxoSmithKline, Pfizer, Johnson an …
Apex Market Reports, recently published a detailed market research study focused on the “Steroid-Corticosteroids Market” across the global, regional and country level. The report provides 360° analysis of “Steroid-Corticosteroids Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Steroid-Corticosteroids on the basis of
Global Precision Medicine Market 2018 - Johnson & Johnson, IBM, GE Healthcare
The statistical surveying information incorporated into the Precision Medicine report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Precision Medicine based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Precision Medicine advertise covering key factors, for example, drivers and
United States Triamcinolone Market Report 2016 : Sanofi, Pfizer, Johnson & Johns …
Qyresearchreports include new market research report "United States Triamcinolone Market Report 2016" to its huge collection of research reports. The research study detailed in the report on the United States Triamcinolone market presents an extensive databank of information that covers all aspects related to the market. Some of these aspects are directly related to the market’s functions. Considering the economic and legal governing factors, the Triamcinolone market is described on the
Johnson & Johnson Sued Over Ortho Evra Damage
FORT WORTH – A Plano, Texas, woman who suffered a miscarriage and developed potentially life-threatening blood clots after using the Ortho Evra® birth control patch has filed a federal lawsuit against drug manufacturing giant Johnson & Johnson (NYSE:JNJ) in Marshall, Texas. Elizabeth Barroso, now 24, began experiencing chest pains and difficulty breathing after using Ortho Evra® for only three weeks in 2004. She spent eight days in the hospital, where